Lutetium lu 177 vipivotide tetraxetan (Intravenous)

Medically reviewed by Drugs.com. Last updated on Feb 9, 2022.

Commonly used brand name(s)

In the U.S.

Pluvicto

Available Dosage Forms:

Solution

Uses for lutetium lu 177 vipivotide tetraxetan

Lutetium Lu 177 vipivotide tetraxetan injection is used to treat prostate-specific membrane antigen (PSMA)-positive metastatic castration-resistant prostate cancer (prostate cancer that is resistant to medical or surgical treatments that lower testosterone and has spread to other parts of the body) in patients who have received other cancer treatments (eg, androgen receptor pathway inhibition, taxane-based chemotherapy).

Lutetium Lu 177 vipivotide tetraxetan is a radiopharmaceutical. Radiopharmaceuticals are radioactive agents, which may be used to find and treat certain diseases or to study the function of the body's organs.

Lutetium lu 177 vipivotide tetraxetan is to be given only by or under the direct supervision of a doctor with specialized training in nuclear medicine.

Before using lutetium lu 177 vipivotide tetraxetan

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For lutetium lu 177 vipivotide tetraxetan, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to lutetium lu 177 vipivotide tetraxetan or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies have not been performed on the relationship of age to the effects of lutetium Lu 177 vipivotide tetraxetan injection in the pediatric population. Safety and efficacy have not been established.

Geriatric

Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of lutetium Lu 177 vipivotide tetraxetan injection in the elderly.

Breastfeeding

There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.

Interactions with medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.

Interactions with food/tobacco/alcohol

Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.

Lutetium lu 177 vipivotide tetraxetan Intravenous